{"gene":"PRRC1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2021,"finding":"PRRC1 is a cytosolic, proline-rich domain-containing protein that is recruited to ER exit sites (ERES), where it interacts with the inner COPII coat. Its absence increases membrane association of COPII, indicating that PRRC1 negatively regulates COPII coat assembly or membrane retention, thereby modulating anterograde trafficking from the ER.","method":"In vitro vesicle formation assay coupled with quantitative mass spectrometry; co-immunoprecipitation to confirm COPII inner coat interaction; PRRC1 depletion with measurement of COPII membrane association; fluorescence microscopy for ERES localization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (in vitro reconstitution assay, quantitative MS, Co-IP, KD with defined biochemical phenotype, localization) in a single rigorous study","pmids":["34433667"],"is_preprint":false},{"year":2025,"finding":"PRRC1 and WDR44 function as cytosolic regulators essential for AP-4-mediated export from the trans-Golgi network (TGN), identifying PRRC1 as an accessory factor for AP-4 vesicle biogenesis.","method":"In vitro vesicle formation assay using AP4ε-deficient HeLa cells reconstituted with wild-type conditions, coupled with label-free quantitative mass spectrometry to identify PRRC1 as enriched in AP-4-dependent vesicles; functional validation through depletion showing loss of AP-4-mediated TGN export","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vitro reconstitution assay combined with quantitative MS and functional depletion with defined trafficking phenotype","pmids":["41032520"],"is_preprint":false},{"year":2026,"finding":"PRRC1 supports proliferative and stress-adaptive transcriptional states in glioblastoma (GBM) cells. shRNA-mediated knockdown in U87 and patient-derived GBM cells reduced proliferation, clonogenic survival, anchorage-independent growth, and 3D spheroid formation. Under genotoxic stress, PRRC1-deficient cells showed enhanced γ-H2AX accumulation, indicating that PRRC1 reduces DNA damage signaling burden and promotes stress tolerance, functionally linking PRRC1 to chromatin organization, cell-cycle regulation, and DNA damage response pathways.","method":"shRNA-mediated knockdown in U87 and patient-derived GBM cell lines; clonogenic survival assay; anchorage-independent growth assay; 3D spheroid formation assay; γ-H2AX immunofluorescence under genotoxic stress; gene set enrichment analysis and MetaCore pathway enrichment for functional annotation","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2/3 — clean KO with defined cellular phenotypes across multiple assays, but mechanistic pathway placement relies substantially on bioinformatic enrichment rather than direct biochemical interaction mapping","pmids":["41932066"],"is_preprint":false}],"current_model":"PRRC1 is a proline-rich cytosolic protein that localizes to ER exit sites and the trans-Golgi network, where it interacts with the inner COPII coat to negatively regulate COPII membrane association during anterograde ER-to-Golgi trafficking, and additionally functions as an accessory factor for AP-4-mediated TGN export; in cancer cells, PRRC1 also supports DNA damage response signaling and stress-adaptive programs that promote tumor cell fitness."},"narrative":{"teleology":[{"year":2021,"claim":"The first mechanistic role for PRRC1 was established at ER exit sites, resolving how a previously uncharacterized proline-rich protein participates in COPII-dependent anterograde trafficking by acting as a negative regulator of COPII coat membrane association.","evidence":"In vitro vesicle formation assay with quantitative mass spectrometry, co-immunoprecipitation for COPII inner coat interaction, PRRC1 depletion showing increased COPII membrane association, and fluorescence microscopy in mammalian cells","pmids":["34433667"],"confidence":"High","gaps":["Structural basis of PRRC1–COPII inner coat interaction is unknown","Whether PRRC1 acts catalytically or as a stoichiometric competitor for COPII binding sites is unresolved","Cargo specificity of PRRC1-regulated COPII vesicles has not been defined"]},{"year":2025,"claim":"PRRC1 was shown to operate at a second trafficking station—the trans-Golgi network—where it serves as an essential cytosolic accessory factor for AP-4-mediated vesicle biogenesis, extending its role beyond ER exit sites.","evidence":"In vitro vesicle formation assay in AP-4ε-deficient HeLa cells reconstituted with wild-type conditions, label-free quantitative mass spectrometry identification, and functional depletion confirming loss of AP-4-mediated TGN export","pmids":["41032520"],"confidence":"High","gaps":["Direct binding interface between PRRC1 and AP-4 coat components has not been mapped","Whether PRRC1 performs analogous negative regulatory functions at the TGN as at ERES, or a distinct activating role, is unclear","Relationship between PRRC1's COPII-regulatory and AP-4-regulatory functions (shared or independent pools) is unknown"]},{"year":2026,"claim":"Beyond vesicular trafficking, PRRC1 was found to support proliferative and stress-adaptive programs in glioblastoma cells, with its loss enhancing DNA damage signaling burden under genotoxic stress, raising the question of whether its trafficking functions feed into genome maintenance indirectly.","evidence":"shRNA-mediated knockdown in U87 and patient-derived GBM lines; clonogenic, anchorage-independent growth, and spheroid assays; γ-H2AX immunofluorescence under genotoxic stress; transcriptomic pathway enrichment","pmids":["41932066"],"confidence":"Medium","gaps":["Mechanistic link between PRRC1's trafficking role and DNA damage tolerance is not established—cancer phenotypes rely on bioinformatic enrichment rather than direct biochemical evidence","Whether PRRC1 acts on chromatin directly or influences DNA damage response indirectly through trafficking-dependent signaling is unknown","Findings have not been replicated outside glioblastoma cell models"]},{"year":null,"claim":"It remains unknown how PRRC1's dual trafficking roles at ERES and the TGN are coordinated, whether its proline-rich domain mediates both COPII and AP-4 interactions through shared or distinct binding interfaces, and whether the cancer-associated phenotypes arise from trafficking dysfunction or a separate nuclear function.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural information exists for PRRC1 or its complexes","In vivo phenotypes in animal models have not been reported","Whether PRRC1 directly participates in chromatin or DNA repair processes has not been tested biochemically"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,1]}],"complexes":[],"partners":["SEC23A","SEC24C","WDR44","AP4E1"],"other_free_text":[]},"mechanistic_narrative":"PRRC1 is a proline-rich cytosolic protein that localizes to ER exit sites and the trans-Golgi network, where it regulates vesicular trafficking at two distinct stations: it interacts with the inner COPII coat to negatively regulate COPII membrane association during ER-to-Golgi transport [PMID:34433667], and it functions as an accessory factor for AP-4-mediated export from the TGN [PMID:41032520]. In glioblastoma cells, PRRC1 depletion impairs proliferation and clonogenic survival and enhances γ-H2AX accumulation under genotoxic stress, indicating an additional role in supporting DNA damage tolerance and stress-adaptive fitness [PMID:41932066]."},"prefetch_data":{"uniprot":{"accession":"Q96M27","full_name":"Protein PRRC1","aliases":["Proline-rich and coiled-coil-containing protein 1"],"length_aa":445,"mass_kda":46.7,"function":"May act as a regulator of the protein kinase A (PKA) activity during embryonic development","subcellular_location":"Golgi apparatus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q96M27/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRRC1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SEC23A","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/PRRC1","total_profiled":1310},"omim":[{"mim_id":"621301","title":"PROLINE-RICH COILED-COIL PROTEIN 1; PRRC1","url":"https://www.omim.org/entry/621301"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PRRC1"},"hgnc":{"alias_symbol":["FLJ32875"],"prev_symbol":[]},"alphafold":{"accession":"Q96M27","domains":[{"cath_id":"-","chopping":"228-255","consensus_level":"medium","plddt":60.0121,"start":228,"end":255},{"cath_id":"3.90.950.10","chopping":"260-440","consensus_level":"high","plddt":96.4499,"start":260,"end":440}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96M27","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96M27-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96M27-F1-predicted_aligned_error_v6.png","plddt_mean":67.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRRC1","jax_strain_url":"https://www.jax.org/strain/search?query=PRRC1"},"sequence":{"accession":"Q96M27","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96M27.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96M27/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96M27"}},"corpus_meta":[{"pmid":"34433667","id":"PMC_34433667","title":"An in vitro vesicle formation assay reveals cargo clients and factors that mediate vesicular trafficking.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34433667","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40371640","id":"PMC_40371640","title":"ST6GalNAc-I regulates tumor cell sialylation via NECTIN2/MUC5AC-mediated immunosuppression and angiogenesis in non-small cell lung cancer.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40371640","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25205603","id":"PMC_25205603","title":"MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.","date":"2014","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/25205603","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24349040","id":"PMC_24349040","title":"Complex variation in measures of general intelligence and cognitive change.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24349040","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41932066","id":"PMC_41932066","title":"Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma.","date":"2026","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/41932066","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41032520","id":"PMC_41032520","title":"Uncovering cargo clients and accessory factors of AP-1 and AP-4 through vesicle proteomics.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/41032520","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21516116","id":"PMC_21516116","title":"Next-generation sequencing to generate interactome datasets.","date":"2011","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/21516116","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16055720","id":"PMC_16055720","title":"WW domains provide a platform for the assembly of multiprotein networks.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16055720","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19322201","id":"PMC_19322201","title":"Ubiquitin-mediated proteolysis of HuR by heat shock.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19322201","citation_count":142,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21832049","id":"PMC_21832049","title":"Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832049","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25959826","id":"PMC_25959826","title":"Quantitative interaction proteomics of neurodegenerative disease proteins.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25959826","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34709727","id":"PMC_34709727","title":"SARS-CoV-2-host proteome interactions for antiviral drug discovery.","date":"2021","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/34709727","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31586073","id":"PMC_31586073","title":"The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31586073","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35256949","id":"PMC_35256949","title":"Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy.","date":"2021","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/35256949","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35044719","id":"PMC_35044719","title":"Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.","date":"2022","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/35044719","citation_count":61,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"36931259","id":"PMC_36931259","title":"A central chaperone-like role for 14-3-3 proteins in human cells.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36931259","citation_count":54,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34732716","id":"PMC_34732716","title":"Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34732716","citation_count":51,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26687479","id":"PMC_26687479","title":"The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26687479","citation_count":44,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27107014","id":"PMC_27107014","title":"An inter-species protein-protein interaction network across vast evolutionary distance.","date":"2016","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/27107014","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32994395","id":"PMC_32994395","title":"Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32994395","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34672954","id":"PMC_34672954","title":"An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.","date":"2021","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/34672954","citation_count":35,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":4639,"output_tokens":1098,"usd":0.015194},"stage2":{"model":"claude-opus-4-6","input_tokens":4326,"output_tokens":1435,"usd":0.086258},"total_usd":0.232228,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":16874,"output_tokens":2408,"usd":0.043371},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":4449,"output_tokens":1441,"usd":0.087405}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"PRRC1 is recruited to ER exit sites, interacts with the inner COPII coat, and its absence increases membrane association of COPII, indicating PRRC1 regulates anterograde trafficking at ER exit sites.\",\n      \"method\": \"In vitro vesicle formation assay, quantitative mass spectrometry, co-immunoprecipitation/interaction studies, loss-of-function analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted in vitro vesicle assay combined with quantitative MS and functional validation in cells showing COPII membrane association phenotype upon PRRC1 depletion\",\n      \"pmids\": [\"34433667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PRRC1 contains a proline-rich domain and associates with vesicle membranes in a GTP-dependent manner, linking its recruitment to COPII vesicle biogenesis at ER exit sites.\",\n      \"method\": \"In vitro vesicle formation assay with GTP dependency, quantitative mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro assay established GTP-dependence; single lab but multiple methods\",\n      \"pmids\": [\"34433667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PRRC1 functions as a cytosolic regulator essential for AP-4-mediated TGN export, identified as an accessory factor for AP-4-dependent vesicle biogenesis at the trans-Golgi network.\",\n      \"method\": \"In vitro vesicle formation assay using AP4ε-deficient HeLa cells, label-free quantitative mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution assay with quantitative MS; single lab, single paper\",\n      \"pmids\": [\"41032520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"shRNA-mediated knockdown of PRRC1 in GBM cells reduces proliferation, clonogenic survival, anchorage-independent growth, and 3D spheroid formation, and causes enhanced γ-H2AX accumulation under genotoxic stress, indicating PRRC1 supports DNA damage response and stress-adaptive states in glioblastoma.\",\n      \"method\": \"shRNA-mediated knockdown, γ-H2AX immunofluorescence, clonogenic and proliferation assays, gene set enrichment analysis\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — clean KD with defined cellular phenotype but no direct molecular mechanism or pathway placement for PRRC1 in DDR\",\n      \"pmids\": [\"41932066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PRRC1 was identified as a fusion partner of MLL in a secondary acute lymphoblastic leukemia patient, with an in-frame 5'MLL–3'PRRC1 fusion gene detected by long-distance inverse-PCR.\",\n      \"method\": \"Long-distance inverse-PCR, fluorescence in situ hybridization, banding cytogenetics\",\n      \"journal\": \"Leukemia research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single case report demonstrating gene fusion; no mechanistic follow-up of fusion protein function\",\n      \"pmids\": [\"25205603\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRRC1 is a cytosolic, proline-rich protein that is recruited to ER exit sites in a GTP-dependent manner, interacts with the inner COPII coat to regulate anterograde trafficking, and additionally serves as an accessory factor for AP-4-mediated vesicle export from the trans-Golgi network.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**CLASSIFICATION:**\n\n**Retrieved Papers:**\n1. PMID:34433667 — Describes PRRC1 as recruited to ER exit sites, interacting with inner COPII coat, regulating anterograde trafficking. **KEEP**\n2. PMID:40371640 — MUC5AC colocalized with PRRC1 in Golgi, but this is a peripheral mention in a paper primarily about ST6GalNAc-I/NECTIN2. The mention of PRRC1 is a correlative observation (\"suggesting a potential role\"), not a direct mechanistic experiment on PRRC1. **EXCLUDE** (no direct mechanistic experiment on PRRC1)\n3. PMID:25205603 — MLL-PRRC1 fusion gene in leukemia; describes chromosomal translocation creating a fusion, not canonical PRRC1 protein mechanism. **EXCLUDE** (fusion gene, not canonical protein function)\n4. PMID:24349040 — GWAS/regional heritability mapping; PRRC1 mentioned as candidate gene via methylation association. No mechanistic experiment. **EXCLUDE** (pure association/expression)\n5. PMID:41932066 — shRNA knockdown of PRRC1 in GBM cells showing proliferation, clonogenic survival, DNA damage phenotypes. Functional validation with defined cellular readouts. **KEEP**\n6. PMID:41032520 — In vitro vesicle formation assay identifies PRRC1 and WDR44 as cytosolic regulators essential for AP-4-mediated TGN export. **KEEP**\n\n**Gene2pubmed Papers:**\n- PMID:12477932 — cDNA sequencing resource. No PRRC1 mechanistic data. **EXCLUDE**\n- PMID:26186194 — BioPlex interactome; large-scale AP-MS, PRRC1 may appear but no specific mechanistic finding. **EXCLUDE** (proteome-scale resource, no specific PRRC1 mechanism)\n- PMID:28514442 — BioPlex 2.0; same as above. **EXCLUDE**\n- PMID:25416956 — Proteome-scale interactome map; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:14702039 — cDNA sequencing. **EXCLUDE**\n- PMID:33961781 — BioPlex 3.0; proteome-scale, no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:21873635 — GO annotation pipeline. **EXCLUDE**\n- PMID:33845483 — SARS-CoV-2 multi-omics; PRRC1 not specifically studied mechanistically. **EXCLUDE**\n- PMID:35271311 — OpenCell localization resource; PRRC1 may be tagged but no specific mechanistic finding described in abstract. **EXCLUDE**\n- PMID:20360068 — MitoCheck chromosome segregation; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:16344560 — Alternative promoters; no PRRC1 mechanism. **EXCLUDE**\n- PMID:26344197 — Metazoan complexes; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:22863883 — SEC/MS interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:21516116 — Stitch-seq interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:16055720 — WW domain interactions; PRRC1 may appear as proline-rich binding partner but no specific mechanistic study. **EXCLUDE**\n- PMID:19322201 — HuR ubiquitination; no PRRC1. **EXCLUDE** (alias collision risk — unrelated)\n- PMID:21832049 — TPPP/p25 interactions; no PRRC1. **EXCLUDE**\n- PMID:25959826 — NDD interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:34709727 — SARS-CoV-2 host proteome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:32814053 — ND interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:31586073 — Midbody interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:35256949 — Parkin/HDAC; no PRRC1. **EXCLUDE**\n- PMID:35831314 — mCF/MS platform; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:35044719 — Peptide-phage display; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:36931259 — 14-3-3 interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:34732716 — SOX2/TRIM26; no PRRC1. **EXCLUDE**\n- PMID:26687479 — PCGF1/PRC1; no PRRC1. **EXCLUDE**\n- PMID:27107014 — Inter-species interactome; no specific PRRC1 mechanism. **EXCLUDE**\n- PMID:32994395 — OGT/XIAP; no PRRC1. **EXCLUDE**\n- PMID:34672954 — SARS-CoV-2 proximity labeling; no specific PRRC1 mechanism. **EXCLUDE**\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"PRRC1 is a cytosolic, proline-rich domain-containing protein that is recruited to ER exit sites (ERES), where it interacts with the inner COPII coat. Its absence increases membrane association of COPII, indicating that PRRC1 negatively regulates COPII coat assembly or membrane retention, thereby modulating anterograde trafficking from the ER.\",\n      \"method\": \"In vitro vesicle formation assay coupled with quantitative mass spectrometry; co-immunoprecipitation to confirm COPII inner coat interaction; PRRC1 depletion with measurement of COPII membrane association; fluorescence microscopy for ERES localization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vitro reconstitution assay, quantitative MS, Co-IP, KD with defined biochemical phenotype, localization) in a single rigorous study\",\n      \"pmids\": [\"34433667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PRRC1 and WDR44 function as cytosolic regulators essential for AP-4-mediated export from the trans-Golgi network (TGN), identifying PRRC1 as an accessory factor for AP-4 vesicle biogenesis.\",\n      \"method\": \"In vitro vesicle formation assay using AP4ε-deficient HeLa cells reconstituted with wild-type conditions, coupled with label-free quantitative mass spectrometry to identify PRRC1 as enriched in AP-4-dependent vesicles; functional validation through depletion showing loss of AP-4-mediated TGN export\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution assay combined with quantitative MS and functional depletion with defined trafficking phenotype\",\n      \"pmids\": [\"41032520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PRRC1 supports proliferative and stress-adaptive transcriptional states in glioblastoma (GBM) cells. shRNA-mediated knockdown in U87 and patient-derived GBM cells reduced proliferation, clonogenic survival, anchorage-independent growth, and 3D spheroid formation. Under genotoxic stress, PRRC1-deficient cells showed enhanced γ-H2AX accumulation, indicating that PRRC1 reduces DNA damage signaling burden and promotes stress tolerance, functionally linking PRRC1 to chromatin organization, cell-cycle regulation, and DNA damage response pathways.\",\n      \"method\": \"shRNA-mediated knockdown in U87 and patient-derived GBM cell lines; clonogenic survival assay; anchorage-independent growth assay; 3D spheroid formation assay; γ-H2AX immunofluorescence under genotoxic stress; gene set enrichment analysis and MetaCore pathway enrichment for functional annotation\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — clean KO with defined cellular phenotypes across multiple assays, but mechanistic pathway placement relies substantially on bioinformatic enrichment rather than direct biochemical interaction mapping\",\n      \"pmids\": [\"41932066\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRRC1 is a proline-rich cytosolic protein that localizes to ER exit sites and the trans-Golgi network, where it interacts with the inner COPII coat to negatively regulate COPII membrane association during anterograde ER-to-Golgi trafficking, and additionally functions as an accessory factor for AP-4-mediated TGN export; in cancer cells, PRRC1 also supports DNA damage response signaling and stress-adaptive programs that promote tumor cell fitness.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PRRC1 is a cytosolic, proline-rich protein that regulates vesicle biogenesis at two distinct trafficking stations. At ER exit sites, PRRC1 is recruited to membranes in a GTP-dependent manner, interacts with the inner COPII coat, and limits COPII membrane association, thereby modulating anterograde transport [PMID:34433667]. PRRC1 also functions as an accessory factor for AP-4-mediated vesicle export from the trans-Golgi network [PMID:41032520].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Before any functional characterization, PRRC1 was identified as a chromosomal translocation partner of MLL in a leukemia case, establishing it as a gene of potential biomedical interest but leaving its normal cellular role entirely unknown.\",\n      \"evidence\": \"Long-distance inverse-PCR and FISH in a single patient with secondary ALL\",\n      \"pmids\": [\"25205603\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single case report with no mechanistic follow-up of fusion protein function\",\n        \"No information on normal PRRC1 cellular role\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The first mechanistic study established that PRRC1 is a GTP-dependently recruited regulator of COPII vesicle biogenesis at ER exit sites, interacting with the inner COPII coat and constraining COPII membrane association — placing it as a novel factor in early secretory pathway trafficking.\",\n      \"evidence\": \"In vitro vesicle formation assays with GTP dependency, quantitative mass spectrometry, co-immunoprecipitation, and loss-of-function analysis in cells\",\n      \"pmids\": [\"34433667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of PRRC1–COPII interaction not resolved\",\n        \"Specific cargo molecules affected by PRRC1 depletion not identified\",\n        \"Whether PRRC1 acts catalytically or as a stoichiometric coat regulator remains unclear\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PRRC1's trafficking role was extended beyond ER exit sites when it was identified as a cytosolic accessory factor essential for AP-4-mediated vesicle biogenesis at the trans-Golgi network, revealing dual-compartment regulatory activity.\",\n      \"evidence\": \"In vitro vesicle formation assay using AP4ε-deficient HeLa cells with label-free quantitative mass spectrometry\",\n      \"pmids\": [\"41032520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct physical interaction between PRRC1 and AP-4 complex subunits not demonstrated\",\n        \"How PRRC1 is differentially recruited to ERES versus TGN is unknown\",\n        \"Single-lab finding awaiting independent replication\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A potential non-trafficking role emerged when PRRC1 knockdown in glioblastoma cells impaired proliferation and enhanced γ-H2AX accumulation under genotoxic stress, linking PRRC1 to stress-adaptive phenotypes, though the direct molecular mechanism is undefined.\",\n      \"evidence\": \"shRNA-mediated knockdown, γ-H2AX immunofluorescence, clonogenic and proliferation assays, gene set enrichment analysis in GBM cells\",\n      \"pmids\": [\"41932066\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No direct molecular mechanism connecting PRRC1 to DNA damage repair established\",\n        \"Whether this phenotype reflects a trafficking-dependent effect (e.g., receptor or signaling factor mislocalization) is untested\",\n        \"Single study without independent confirmation\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the structural basis of PRRC1 interactions with COPII and AP-4 machinery, the identity of specific cargoes regulated by PRRC1, and whether the proliferative and DNA damage phenotypes observed in cancer cells are downstream of its vesicle trafficking function.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of PRRC1 or its complexes\",\n        \"No defined cargo specificity for PRRC1-dependent vesicles at either ERES or TGN\",\n        \"Relationship between trafficking and cancer-associated phenotypes unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SEC23\",\n      \"SEC24\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PRRC1 is a proline-rich cytosolic protein that localizes to ER exit sites and the trans-Golgi network, where it regulates vesicular trafficking at two distinct stations: it interacts with the inner COPII coat to negatively regulate COPII membrane association during ER-to-Golgi transport [PMID:34433667], and it functions as an accessory factor for AP-4-mediated export from the TGN [PMID:41032520]. In glioblastoma cells, PRRC1 depletion impairs proliferation and clonogenic survival and enhances γ-H2AX accumulation under genotoxic stress, indicating an additional role in supporting DNA damage tolerance and stress-adaptive fitness [PMID:41932066].\",\n  \"teleology\": [\n    {\n      \"year\": 2021,\n      \"claim\": \"The first mechanistic role for PRRC1 was established at ER exit sites, resolving how a previously uncharacterized proline-rich protein participates in COPII-dependent anterograde trafficking by acting as a negative regulator of COPII coat membrane association.\",\n      \"evidence\": \"In vitro vesicle formation assay with quantitative mass spectrometry, co-immunoprecipitation for COPII inner coat interaction, PRRC1 depletion showing increased COPII membrane association, and fluorescence microscopy in mammalian cells\",\n      \"pmids\": [\"34433667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of PRRC1–COPII inner coat interaction is unknown\",\n        \"Whether PRRC1 acts catalytically or as a stoichiometric competitor for COPII binding sites is unresolved\",\n        \"Cargo specificity of PRRC1-regulated COPII vesicles has not been defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"PRRC1 was shown to operate at a second trafficking station—the trans-Golgi network—where it serves as an essential cytosolic accessory factor for AP-4-mediated vesicle biogenesis, extending its role beyond ER exit sites.\",\n      \"evidence\": \"In vitro vesicle formation assay in AP-4ε-deficient HeLa cells reconstituted with wild-type conditions, label-free quantitative mass spectrometry identification, and functional depletion confirming loss of AP-4-mediated TGN export\",\n      \"pmids\": [\"41032520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct binding interface between PRRC1 and AP-4 coat components has not been mapped\",\n        \"Whether PRRC1 performs analogous negative regulatory functions at the TGN as at ERES, or a distinct activating role, is unclear\",\n        \"Relationship between PRRC1's COPII-regulatory and AP-4-regulatory functions (shared or independent pools) is unknown\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Beyond vesicular trafficking, PRRC1 was found to support proliferative and stress-adaptive programs in glioblastoma cells, with its loss enhancing DNA damage signaling burden under genotoxic stress, raising the question of whether its trafficking functions feed into genome maintenance indirectly.\",\n      \"evidence\": \"shRNA-mediated knockdown in U87 and patient-derived GBM lines; clonogenic, anchorage-independent growth, and spheroid assays; γ-H2AX immunofluorescence under genotoxic stress; transcriptomic pathway enrichment\",\n      \"pmids\": [\"41932066\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic link between PRRC1's trafficking role and DNA damage tolerance is not established—cancer phenotypes rely on bioinformatic enrichment rather than direct biochemical evidence\",\n        \"Whether PRRC1 acts on chromatin directly or influences DNA damage response indirectly through trafficking-dependent signaling is unknown\",\n        \"Findings have not been replicated outside glioblastoma cell models\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how PRRC1's dual trafficking roles at ERES and the TGN are coordinated, whether its proline-rich domain mediates both COPII and AP-4 interactions through shared or distinct binding interfaces, and whether the cancer-associated phenotypes arise from trafficking dysfunction or a separate nuclear function.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural information exists for PRRC1 or its complexes\",\n        \"In vivo phenotypes in animal models have not been reported\",\n        \"Whether PRRC1 directly participates in chromatin or DNA repair processes has not been tested biochemically\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SEC23A\",\n      \"SEC24C\",\n      \"WDR44\",\n      \"AP4E1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}